The Patent Finder

Janssen-Cilag S.A., Edificio Johnson & Johnson

Also on record
Records under this name other than patents Janssen-Cilag S.A., Edificio Johnson & Johnson holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 10 of 10 · Back to Janssen-Cilag S.A., Edificio Johnson & Johnson

PatentTitleStatus Expires Confidence
US 8,906,9214-Alkoxypyridazine Derivatives as Fast Dissociating Dopamine 2 Receptor Antagonists
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,933,101Thia(DIA)zoles as Fast Dissociating Dopamine 2 Receptor Antagonists
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,895,562PIPERAZIN-1-YL-TRIFLUOROMETHYL-SUBSTITUTED-PYRIDINES as Fast Dissociating Dopamine 2 Receptor Antagonists
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,852,554Radiolabelled PDE10 ligands
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,859,543IMIDAZO[1,2-a]PYRAZINE DERIVATIVES AND THEIR USE FOR THE PREVENTION OR TREATMENT OF NEUROLOGICAL, PSYCHIATRIC AND METABOLIC DISORDERS AND DISEASES
Lapsed on the fee record
Ended Oct 14, 2026 · High confidence
Lapsed on the fee recordEnded Oct 14, 2026High confidence
US 8,530,474Substituted 6-(1-Piperazinyl)-PYRIDAZINES as 5-HT6 Receptor Antagonists
Formerly held
Lapsed on the fee record
Ended Sep 10, 2025 · High confidence
Lapsed on the fee recordEnded Sep 10, 2025High confidence
US 7,476,662Substituted tetracyclic imidazole derivatives, processes for their preparation, pharmaceutical compositions comprising them and their use as a medicine
Term ended
Term ended Jul 30, 2023 · From the USPTO record
Term endedTerm ended Jul 30, 2023From the USPTO record
US 9,012,4481,2,4-Triazolo[4,3-a]pyridine Derivatives and Their Use as Positive Allosteric Modulators of MGLUR2 Receptors
Lapsed on the fee record
Ended Apr 21, 2023 · High confidence
Lapsed on the fee recordEnded Apr 21, 2023High confidence
US 9,174,953Bicyclic Thiazoles as Allosteric Modulators of MGLUR5 Receptors
Formerly held
Lapsed on the fee record
Ended Nov 3, 2019 · High confidence
Lapsed on the fee recordEnded Nov 3, 2019High confidence
US 9,040,707Bicyclic Thiazoles as Allosteric Modulators of MGLUR5 Receptors
Formerly held
Lapsed on the fee record
Ended May 26, 2019 · High confidence
Lapsed on the fee recordEnded May 26, 2019High confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited